ADVI Health

ADVI Health is a strategic consulting firm serving the healthcare and life sciences ecosystem with specialized expertise in commercialization, market access, and policy. The firm supports clients across the product lifecycle, from development through market delivery, with particular depth in navigating complex reimbursement landscapes including Medicare, Medicaid, VA-DOD, and private payer systems.

The firm's service portfolio spans five core solution areas: Strategic Analytics, Value and Economics; Coding and Reimbursement; Financial Services Due Diligence; Market Access and Pricing Strategy; and Policy, Research, and Analysis. ADVI Health's team comprises former policymakers, market access professionals, and industry veterans who provide real-time policy monitoring and customized analytical models. The firm has demonstrated experience with novel therapeutics including CAR-T cell therapies, gene therapies, digital therapeutics, and medical devices.

ADVI Health distinguishes itself through access to real-time datasets and actionable analytical products. The firm maintains extensive case study documentation across pharmaceuticals, biotech, medical devices, diagnostics, and digital health, with particular expertise in rare disease commercialization and inflation Reduction Act navigation.

Choose ADVI Health when launching novel therapeutics requiring sophisticated reimbursement strategy or navigating complex federal policy landscapes. The firm excels in situations requiring both technical coding expertise and strategic policy positioning, particularly for innovative products without established payment pathways.

Expect data-driven analysis combining claims-based research with policy expertise. The firm's team of former policymakers and market access veterans provides both strategic guidance and tactical execution support throughout the product lifecycle.

ADVI Health exclusively serves the healthcare and life sciences ecosystem with 100% focus on commercialization, market access, and policy needs. The firm specializes in navigating U.S. healthcare payment systems including Medicare prospective payment systems, Medicaid reimbursement, and private payer medical policy. Specific healthcare verticals include pharmaceuticals, biotech, medical devices, diagnostics, digital therapeutics, and cell and gene therapies.

The firm demonstrates particular expertise in healthcare-specific regulatory frameworks including CPT and HCPCS coding, LCD/NCD coverage determinations, and compliance with Medicare payment policies across settings of care.

Pharmaceutical, biotech, and medical device companies launching innovative products requiring Medicare Part B or Part D reimbursement strategy. Life sciences firms seeking policy analysis on legislative impacts. Private equity and venture capital firms conducting healthcare investment due diligence. Organizations requiring specialized expertise in cell and gene therapy market access or rare disease commercialization.